摘要: Prostate cancer (PCa) is the second most common malignancy among men in the world. Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which develops upon resistance to ifrst line androgen deprivation therapy (ADT). Emerging evidence demonstrates a key role for the PI3K-AKT-mTOR signaling axis in the development and maintenance of CRPC. This pathway, which is deregulated in the majority of advanced PCas, serves as a critical nexus for the integration of growth signals with downstream cellular processes such as protein synthesis, proliferation, survival, metabolism and differentiation, thus providing mechanisms for cancer cells to overcome the stress associated with androgen deprivation. Furthermore, preclinical studies have elucidated a direct connection between the PI3K-AKT-mTOR and androgen receptor (AR) signaling axes, revealing a dynamic interplay between these pathways during the development of ADT resistance. Thus, there is a clear rationale for the continued clinical development of a number of novel inhibitors of the PI3K pathway, which offer the potential of blocking CRPC growth and survival. In this review, we will explore the relevance of the PI3K-AKT-mTOR pathway in PCa progression and castration resistance in order to inform the clinical development of speciifc pathway inhibitors in advanced PCa. In addition, we will highlight current deifciencies in our clinical knowledge, most notably the need for biomarkers that can accurately predict for response to PI3K pathway inhibitors.
-
生活方式对亚洲男性性激素、性活动以及老龄化的调节作用
-
70W和120W2微米激光汽化切除良性前列腺增生的体外对比研究
-
中国人类精子库捐精现状及应用:7年多中心回顾性研究
-
西地那非联合多沙唑嗪缓释剂治疗勃起功能障碍合并良性前列腺增生相关下尿路症状患者疗效的开放对照多中心临床评估
-
体重指数及血脂水平与血清前列腺特异抗原的关系:一组中国50岁以下人群的研究
-
血清PSA水平与非癌变前列腺组织体积的比值是接受前列腺癌根治术患者局部晚期前列腺癌生化复发的新指标
-
人精子纤维鞘内CABYR蛋白与AKAP3及Ropporin蛋白结合
-
芳香化酶(CYP19)基因变体同精子浓度和活性的关系
-
治疗前列腺癌的化疗新策略:一种新的Eg5抑制剂S-(methoxytrityl)-L-cysteine
-
ERβ基因RsaI多态性可能降低精子受精力及胚胎的发育潜能